Slower than Breakneck

Premium

I was in college when the first draft of the human genome came out. Not long after, Craig Venter came to my university to speak at convocation about the Human Genome Project — the biology department was quite excited and many of us biology majors went, despite usually skipping convocation to do almost anything else. The title of Venter's talk was "Sequencing the Human Genome: Gateway to a New Era in Science and Medicine." At the 10th anniversary of the draft genome last year, some of that ebullience was glaringly absent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.